Rectify Pharma @RectifyPharma
Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases. rectifypharma.com Boston, MA Joined September 2021-
Tweets151
-
Followers125
-
Following94
-
Likes5
At #EASLCongress 2026 we are presenting new translational data with our clinical candidate RTY-406 that further supports its potential as a first-in-class disease-modifying treatment for PSC and other hepatobiliary diseases. Learn more: bit.ly/4wXBm6Y
Heading to #EASLCongress 2026? We look forward to connecting with the global liver community & sharing new preclinical data on RTY-406, our dual ABCB4/BSEP #PFMs candidate in development for #PSC & other hepatobiliary diseases. Learn more: bit.ly/3PCZXgn
Our new publication in Liver International Communications demonstrates how partial loss of ABCB4 function causes toxic bile composition and drives inflammation, fibrosis and liver injury. Read more: bit.ly/48ofBSW
Protein dysfunction frequently underlies the development of serious diseases. At Rectify, we are advancing precision approaches to restore protein function and address underlying drivers of disease. Learn more: bit.ly/3V5Vul7
#PrimarySclerosingCholangitis brings daily uncertainty and complex challenges for patients and caregivers. Supporting and advocating for this community is essential. Learn more about our work in #PSC: bit.ly/3V5Vul7
Our CEO, @r_devraj, will join the “Pipeline Prioritization” panel at @LongwoodLeaders #MiamiCEO, convening leaders across the biotech, pharma, academia, regulatory & investment communities to discuss key issues shaping life sciences. Learn more: bit.ly/425tPFL
In support of #RareDiseaseDay, we stand with the millions affected by rare diseases worldwide. At Rectify, this fuels our commitment to advance science for rare hepatobiliary diseases. Learn more: bit.ly/3IlLQn0
Rare hepatobiliary diseases often mean delayed diagnosis, limited options, and daily symptoms that affect quality of life. At Rectify, we are developing #PFMs to restore protein function and address hepatobiliary diseases like #PSC. Learn more: bit.ly/3V5Vul7
Our CEO @r_devraj joined The BioHub Podcast to discuss Rectify’s vision for advancing a new class of oral small molecules: our #PFMs. Here, Raj shares how we’re prioritizing unmet medical needs in diseases like #PSC. Tune in here: bit.ly/3OnU4CN
Over 50% of cholestatic chronic liver disease patients carry pathogenic variants in ABCB4 or BSEP, with ABCB4 heterozygosity, the most common genotypic burden seen in 74% of cases. Our dual ABCB4/BSEP PFM offers a targeted therapy for this growing, underserved patient population.
New research shows over 50% of adults with cholestatic chronic liver disease carry pathogenic variants in bile transporter genes, including ABCB4 and BSEP. This supports why @Rectify Pharma is advancing an oral, dual-targeted ABCB4/BSEP PFM. Read more: pmc.ncbi.nlm.nih.gov/articles/PMC12…
A new year brings renewed focus on science that can change what’s possible for future patients. At Rectify, we remain committed to advancing disease-modifying therapies and translating discovery into real-world impact.
#NEWS: Chronic kidney disease impacts ~1 in 10 adults (~850 million people). Together with @RectifyPharma, we’re targeting underlying disease mechanisms linked to calcification and cardiorenal risk. Learn more at go.boehringer.com/mPnXJ #ResearchCollaboration #CKD
We’re pleased to partner with @Boehringer to advance new treatments for chronic kidney disease (#CKD) & other conditions. We will leverage our #PFM platform to develop oral therapies that enhance ABCC6 function to address cardiorenal dysfunction. Read: bit.ly/4j9TZhf
How can restoring transporter function help rare liver diseases like PSC? Our CMO Dr. Pol Boudes, MD explains Rectify’s dual-modulator strategy and potential clinical plans on @XTalks. Listen here: bit.ly/49pRYuH
Primary Sclerosing Cholangitis (PSC) causes bile duct scarring and blocked bile flow. Our #PositiveFunctionalModulators (PFMs) aim to restore bile transport, reduce inflammation, and slow disease even without a genetic cause. Learn more: cle.clinic/3W2RNha
#DYK? PBC was renamed from Primary Biliary Cirrhosis, since patients now get diagnosed before cirrhosis. Similarly, PSC patients are diagnosed before bile duct sclerosis. Fact: PSC starts as inflammation from toxic bile harming bile duct cells. Should PSC get a new name too?
From rare genetic disorders to more common conditions, hepatobiliary diseases highlight the complexity of liver health. This #LiverDiseaseAwarenessMonth, we remain focused on pioneering PFMs to restore function where it’s needed most. Learn more: bit.ly/3IMoHz3
#PSC is a chronic liver disease causing bile duct inflammation and fibrosis. Our #PositiveFunctionalModulators (PFMs) enhances bile transporter function, improving bile flow and reducing inflammation. We aim to transform PSC treatment. Learn more: bit.ly/3V5Vul7
By targeting the root causes of disease, we aim to deliver therapies that truly modify disease progression. Our #PositiveFunctionalModulators are oral small molecules designed to transform the function of membrane proteins. Learn more: bit.ly/3IMoHz3
Alexa K @les4milles
5 Followers 280 Following love me? great. hate me? also great, enemies to lovers is a good trope
Andy @Andy68255998
73 Followers 2K Following
Amir H K Ashkezari @Datstoogood
13 Followers 413 Following Biophysics enthusiast, PhD candidate @chengzhulab Georgia Tech
Chaminda Silva @CmailsLk
2 Followers 68 Following
![Chief, Medical Genetics & Human Variation; NCBI|NLM|NIH. Adventurous info seeker chasing 3 happy boys and 1 fab hub. Messy desk, full heart. #MSU [Views my own]](https://pbs.twimg.com/profile_images/448904062621458432/yf9GMvJF.jpeg)
Brandi Kattman @brandikattman
309 Followers 1K Following Chief, Medical Genetics & Human Variation; NCBI|NLM|NIH. Adventurous info seeker chasing 3 happy boys and 1 fab hub. Messy desk, full heart. #MSU [Views my own]
Ewa @E11watthh11
83 Followers 103 Following
LowPE_Gems🇺🇸 @Rujook758736
55 Followers 2K Following 15-30% Monthly | 2 High-Conviction Stocks.Short-Term Gains: 15-20% in Days/Weeks.DM "JOIN" for WhatsApp Alerts. Live Trade Signals • Market Analysis
Alīna Reķēna @alina_rekena
59 Followers 163 Following Systems and synthetic biology, from PhD on to the next adventures
Ibrahim N @ibrahimbdkl
102 Followers 602 Following
LetPub @LetPub
471 Followers 3K Following Research communication resources & insights for PhD researchers & STEM journal editors https://t.co/Yjv8CC1ESu & https://t.co/cEunh3OpQn
qweqwe @qweqwe174101
15 Followers 218 Following
Fernando Medhurst @FernandoMe47301
67 Followers 1K Following
Kari Watson @Kari_M_Watson
740 Followers 2K Following Life science business advisor & comms strategist. Mom. @WilliamsCollege Eph. Avid golfer, hiker and snowboarder. Opinions are my own.
LifeSci Communication... @LifeSciComms
1K Followers 1K Following Global communications and marketing agency focused on #LifeSciences and #MedTech companies.
Clora @MeetClora
189 Followers 261 Following The best place to discover, build, and manage on-demand life science teams.
Lego @LEGOJELLO
19 Followers 236 Following
Gorethee @Gorethee186954
39 Followers 3K Following
anirudh mantri @mantri_anirudh
71 Followers 794 Following Graduate student @schmeinglab @mcgillu Passionate about proteins, mega-enzymes, natural products
Leeneski @LeeneskiOA0T7t
86 Followers 7K Following
Michael Rubenstein @michaelrube0
63 Followers 426 Following Manager of Corporate Affairs for Antech Diagnostics, a Mars Petcare company Previously Media Relations at @LifeSciComms | Public Relations at @EmersonSOC
BlancheHarold @ga4Udd5R8k336
67 Followers 7K Following
LOG Pharma Packaging @LOGPharma
82 Followers 1K Following LOG Pharma Primary Packaging is a leading global provider of innovative and sustainable #packaging solutions for the #pharmaceutical industry.
Saraswathi pillai @Saraswathi_jp
80 Followers 826 Following Staff Associate working at Aydogan lab, Columbia University on unravelling the role of ROS in embryogenesis
Emily @2x9W66S622a3bq
186 Followers 7K Following
Baresare @BaresareRO7Bc
40 Followers 4K Following
Chris Mathes @MathesChris
2K Followers 3K Following Ion Channel & Drug Discovery professional who develops business
Kate @KatherineMeeks_
1 Followers 36 Following
Thaminda Ramanayake �... @thaminda19
979 Followers 4K Following Biopharma executive & strategist | Dealmaker, negotiator (ex-CureVac, Sanofi, BioMarin, Amgen) | Sharing insights on biotech + wisdom on human relationships
AliceSouthey @J0t18e6P36WB2
102 Followers 2K Following
PrudenceSidney @ey3Ov81YHg0I3
28 Followers 3K Following
BioProcure, Inc. @bioprocure
248 Followers 625 Following Procure-to-Pay Down to a Science. Founded in 2007, BioProcure offers strategic sourcing & procurement services and admistrative & accounts payable support.
Prendio @Prendio_MA
262 Followers 840 Following Accelerating R&D while saving you time and money! Check us out to see why Prendio is the premier eprocurement solution for biotech.
Cancer Research Horiz... @CR_Horizons
2K Followers 2K Following We are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
Wren @Wren91110097278
44 Followers 2K Following
BethanyTyska @BethanyTys42693
36 Followers 2K Following
Nesisesh @nesisesh16203
71 Followers 1K Following Chúc bạn vui vẻ ,Thay vì vui mừng ,Tôi hy vọng bạn không có điểm yếu ,Và cũng Ko cần Áo giáp
Patrick Stoiber @PatrickStoib
0 Followers 1 Following
Heidi Ulrichs @Heidis_Cells
202 Followers 183 Following Just a biochemistry PhD student trying to figure out how to navigate science twitter
Becky Haeusler @RebeccaHaeusler
738 Followers 725 Following Metabolism, insulin, bile acids, lipids at Columbia University. Tweets mine. she/her
Dethoughd @dethoughd58494
39 Followers 1K Following
Tracey Dawson @tracey_dawson
39 Followers 199 Following born, lived and still living, loves to work and works to live, live everyday you are blessed with and always have a positive mental attitude!
Investors.com @IBDinvestors
439K Followers 584 Following Investor's Business Daily is guiding investors of all experience levels through the stock market using time-tested strategies and actionable insights.
Miles Kruppa @MilesKruppa
4K Followers 2K Following Journalist. Ex-@theinformation, @WSJ and @FT. Get in touch: [email protected].
Joseph Cotterill @jsphctrl
33K Followers 1K Following Emerging Markets correspondent @FinancialTimes. I insist you go to Bluesky.
Financial Times @FinancialTimes
7.2M Followers 989 Following This account is now closed. For the best of FT journalism, including breaking news and analysis, follow @ft
Katie Jennings @katiedjennings
6K Followers 3K Following VP for comms & strategy @cbcny | Formerly @Forbes, @Bagehots, @POLITICO
Leah Rosenbaum @leah_rosenbaum
4K Followers 3K Following Investigative reporter covering military & veterans @TheWarHorseNews. Formerly: @BusinessInsider, @Forbes. Signal: leahrosenbaum.01
Forbes @Forbes
20.3M Followers 5K Following Sign up now for Forbes' free daily newsletter for unmatched insights and exclusive reporting: https://t.co/v3UAa9BzAT
Venture Capital Journ... @VCJournal
7K Followers 768 Following Twitter stream for readers of Venture Capital Journal.
Dealreporter @Dealreporter
11K Followers 271 Following An Acuris company, our news and data cover Mergers and Acquisitions, Special Situations and Equity Capital Markets (ECM) in real-time, with 67 global bureaus.
SteveGelsi @SteveGelsi
2K Followers 1K Following Ex-staff news reporter focused on banking and cannabis at https://t.co/AFy0FUotys. Former private equity writer at The Deal and Buyouts magazine.
The Deal by S&P Globa... @TheDealNewsroom
21K Followers 3K Following Our newsroom has been serving corporate dealmakers, advisers and institutional investors the most sophisticated analysis of the deal economy since 1999.
Owen Thomas @owenthomas
19K Followers 10K Following Managing editor, @SFBusinessTimes. Former @protocol, @sfchronicle, etc. Always @alex's #Twitterdad. Email: othomas at bizjournals dot com
Barron's @barronsonline
404K Followers 39 Following The world's premier investing publication since 1921. For customer support, visit https://t.co/HkyUtq6BNr
Leslie Picker @LesliePicker
29K Followers 2K Following CNBC Senior Banking & Finance Correspondent https://t.co/zFrCI92DJh
Bloomberg TV @BloombergTV
881K Followers 565 Following Breaking news. In-depth analysis. Market-moving scoops. Exclusive interviews. Sign up for the Wall Street Week newsletter: https://t.co/RPmABSzqpH
Sonali Basak @sonalibasak
61K Followers 5K Following Chief Investment Strategist for iCapital. Previously anchor for @BloombergTV & journalist @business. @NYUStern MBA. Views are my own.
Biz Carson @bizcarson
26K Followers 2K Following Bloomberg reporter covering @wealth in CA. Ex-Protocol, Forbes, Business Insider, Gigaom, & Wired. Atlanta native, IU Hoosier. Email: [email protected]
PE HUB @PEHUB
38K Followers 444 Following #privateequity #pe and #venturecapital #vc news, analysis and data.
Vishal Persaud @vishalpersaud
969 Followers 1K Following Tech PR media strategist @OffleashPR | Former Bloomberg, Business Insider | @dartmouth @newmarkjschool alum | Bronx, NY-born 🇬🇾, @yankees @nyknicks fan
April Joyner @aprjoy
4K Followers 2K Following Business + tech writer. Not posting here now: find me on Bluesky with the same handle.
Ben Bergman @thebenbergman
11K Followers 880 Following Senior Correspondent @BusinessInsider, investigating VC/startups. Big into tennis, skiing and poker. Got a tip? Message me securely on Signal: BenBergman.11
Insider @thisisinsider
401K Followers 613 Following What you want to know. Follow us on Facebook, Instagram, TikTok, and YouTube. Visit our homepage for the day's top stories.
The New York Times @nytimes
53.5M Followers 846 Following News tips? Share them here: https://t.co/ghL9OoYKMM
Gillian Tan @GillianTan
20K Followers 587 Following
Bloomberg @business
10.2M Followers 105 Following The first word in business news | Watch Live: https://t.co/nHEpHOAfg3 | Newsletters: https://t.co/nWaCxHTiks | Podcasts: https://t.co/096e9xMJF7
Lizette Chapman @lizette_chapman
10K Followers 5K Following Covering defense tech startups and the VCs who back them. Reporter @Bloomberg @Technology. Eternal optimist, mom of 3, aspiring saxophonist. Signal: LCVixe.18
Business Insider @BusinessInsider
4.2M Followers 397 Following What you want to know about business. Love Business Insider? Add us as a preferred source on Google.
Dan Primack @danprimack
161K Followers 5K Following Biz editor @Axios. Pro Rata newsletter. [email protected]. Native Masshole. DM for Signal/Telegram.
Axios @axios
839K Followers 1K Following Smart Brevity worthy of people's time, attention and trust. Subscribe to our newsletters: https://t.co/uMitaJIcpz
Frank Vinluan @frankvinluan
2K Followers 751 Following Business journalist based in #RTP, covering pharma and biotech (almost) everywhere. 71% free throw shooter. Genesis: Album 9, track 11.
Alex Keown @alexkeown
1K Followers 970 Following Man of faith, #AppState alumni, journalist, writer for #OnwardBoundRPG Author: Pains of the Past https://t.co/pJVSlppCGp
Elizabeth Cooney @cooney_liz
2K Followers 1K Following Reporter at @statnews. Writer. Runner. Opinions my own.
Amirah Al Idrus 🏳�... @amirahalidrus
935 Followers 756 Following Recovering rugby player. Poutine fanclub. Baker (and eater) of pies. She/her/hers.
Marc Vartabedian @marcvarta
2K Followers 1K Following Reporter covering tech for the New York Post / California Post
Lucinda Shen @ShenLucinda
9K Followers 2K Following Covering deals @axios. Formerly @fortunemagazine. Reach me lucinda.shen (@)https://t.co/yxq3OmkLrT. DM for signal and everything else.
The Wall Street Journ... @WSJ
21.5M Followers 1K Following Sign up for our newsletters and alerts: https://t.co/QevH0DLQi8 | Got a tip? https://t.co/iXIigdPjEZ | For WSJ customer support: https://t.co/DZgH9n53qg
FierceBiotech @FierceBiotech
102K Followers 627 Following The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Endpoints News @endpts
32K Followers 80 Following The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://t.co/qpcDlbaOSx
John Carroll @JohnCendpts
71K Followers 109 Following Capped a 48-year journalism career with a decade-long (and counting) run as founding editor at Endpoints News. Writing a book on cancer care in America: Stage 4
Luke Timmerman @ldtimmerman
35K Followers 253 Following Biotech journalist. Founder @TimmermanReport.
Ben Fidler @BentheFidler
8K Followers 670 Following Biotech Journalist; Lead Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy.
Alex Lash @alexlash
6K Followers 612 Following Editor @TheFrisc: independent nonprofit news/analysis for an ever-changing San Francisco (my hometown). Past writing lives include biotech, baseball, and tech.
BioCentury @BioCentury
17K Followers 2K Following The leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://t.co/V33Z1gfUfZ
You might like
